A specific pink has taken over the beauty shops on my street in Seongsu, a cool bubblegum that reads as clinical and as candy. It is the color Medicube chose for its salmon line, and the bottles sit in a lit row by the register the way cigarettes used to. Last week I watched a woman in her thirties skip the shelf and ask the clerk for "the salmon one." She did not say polydeoxyribonucleotide, or PDRN, or polynucleotide, or any of the words on the box. She asked for the fish, and the clerk knew exactly what she meant.
That is the story in one gesture. Salmon DNA has become the rare ingredient that people request by name, and the name is doing work the molecule cannot always back up. The search-analytics firm Spate clocked searches for PDRN serum growing about 1,400 percent year over year, off a small base but faster than nearly anything in beauty. Medicube, the Korean brand that made the trend a checkout aisle, now puts PDRN in more than 30 percent of its range, its US marketing head Lyla Chang told Business of Fashion; the line's investment, she said, is "roughly twice as large" as standard skincare.
So it is worth being honest about what you are buying: two products wear this name and are not the same.
Start with the one that earned the reputation. PDRN is a family of DNA fragments purified from salmon or trout. In the clinic it is sold as PN, the longer chains (Rejuran); the serums say PDRN, the shorter fragments; both are the same salmon DNA. As an injected drug it has a serious clinical past. The first commercial version, Placentex, came out of Italy decades ago as a wound-healing medicine. The trial people reach for came from Francesco Squadrito's group in Messina, a randomized, double-blind, placebo-controlled study of 216 patients with stubborn diabetic foot ulcers. Injected PDRN closed the wound completely in 37.3 percent of patients against 18.9 percent on placebo over eight weeks, roughly a doubling, and cut the median time to heal from forty-nine days to thirty. That is real medicine. The mechanism is real too: PDRN acts on the adenosine A2A receptor, calming inflammation and coaxing new blood vessels and collagen. Those receptors sit on fibroblasts, down in the dermis.
And there, in that last word, is the problem. The dermis lies under the epidermis, under the stony outer wall of the stratum corneum, and that wall is picky about what it lets through. The rough guide dermatologists use is the 500 Dalton rule: molecules much heavier than 500 daltons do not cross intact skin on their own. PDRN runs from roughly 50,000 to 1,500,000 daltons. It is not a little over the limit. It is a hundred to three thousand times over it. A serum you smooth onto unbroken skin, however lovely it feels, cannot carry that molecule to the fibroblasts where the evidence says it works. The clinical wins that built its reputation all came through a needle.
Dr. Nina Hartman, a dermatologist in Washington, put it plainly to NewBeauty: topical PDRN products "can support overall skin health but lack the deeper impact of injections." The serum is not a fraud. It hydrates, its peptides and niacinamide do their own modest work, and it feels expensive on the back of the hand. It simply is not the thing in the syringe.
Here is the part that would surprise the woman buying the salmon one. In the United States, the injectable she trusts is not approved. The FDA's list of approved injectable fillers runs to hyaluronic acid and a few other materials; no salmon-DNA product is on it, and injectable skin boosters like Rejuran are a separate category the agency has not cleared for injection at all. The topical serums are legal only because cosmetics need no approval. So the American "salmon sperm facial," the one Kim Kardashian showed off on her reality show in 2024, is usually a topical laid over microneedling, an off-label workaround. The premium name rests on an injectable that Americans cannot legally get.
At home in Korea the word means something older and less borrowed. Pharmaresearch built Rejuran here out of that same Italian medicine, and its founder, Jung Sang-soo, came from Gangneung, on the coast in Korea's largest salmon-spawning ground, where the company still sits. For years salmon DNA was something you got on a clinic table in Gangnam, numbing cream first, a course of monthly visits, a price that felt like medicine because it was medicine. When a Korean woman hears salmon, she hears the clinic, the doctor, the decade of trust, and the drugstore serum inherits all of it for twenty-six dollars.
Chang says Medicube does not "just chase the next big molecule," that it wants actives that "withstand scientific scrutiny." I believe the molecule withstands it. The question the name skips is whether it can get in. So buy the salmon one if you like how it feels, and I do, a little. Just keep the two straight: the word on the box has a pedigree the serum inside only borrows, and the strongest thing PDRN has shown, it showed through a needle, not a fingertip.
